BLOOD clots should be listed as a "very rare" side effect of the Johnson & Johnson coronavirus vaccine but its benefits still outweigh the risks, the EU's drug watchdog said on Tuesday.
The European Medicines Agency (EMA) said in a statement that it had found a "possible link" between the jab and the clots, following eight such cases in the United States, one of which was fatal.
Concerns over the vaccine by US pharmaceutical giant Johnson & Johnson and the jab by rival drugmaker AstraZeneca have dampened hopes that vaccines could offer a swift end to the pandemic.
"EMA finds possible link to very rare cases of unusual blood clots with low blood platelets," the Amsterdam-based agency said in a statement, adding that it "confirms (the) overall benefit-risk remains positive."
The regulator said its safety committee "concluded that a warning about unusual blood clots with low blood platelets should be added to the product information" for the J&J shot.
Its experts also "concluded that these events should be listed as very rare side effects of the vaccine."
"The cases reviewed were very similar to the cases that occurred with the Covid-19 vaccine developed by AstraZeneca, Vaxzevria," the EMA statement said.
The eight cases in the US, out of some seven million people who had received the vaccine, all involved people under the age of 60, the majority of whom were women, it said.
"Based on the currently available evidence, specific risk factors have not been confirmed," the EMA said.
EMA chief Emer Cooke was due to hold a press conference on the decision at 1500 GMT.
- Adenovirus technology -
Johnson & Johnson last week delayed the rollout of its single-shot jab across Europe pending the result of the EMA probe.
J&J said earlier Tuesday that it was "very confident" in its vaccine and hopeful for a quick resolution from regulators over its status.
The EU approved the Johnson & Johnson shot on March 11 and started taking delivery of the vaccine on April 19.
But with concerns already mounting over clots linked to AstraZeneca, the EMA announced on April 9 that it was also probing cases connected to the J&J vaccine.
US regulators have suspended the Johnson & Johnson vaccine and is set to announce its decision on Friday.
Both the Johnson & Johnson and AstraZeneca vaccines use the same adenovirus vector technology.
They use a common-cold causing adenovirus, modified so it cannot replicate, as a "vector" to shuttle genetic instructions into human cells, telling them to create a protein of the coronavirus, and training them to be ready for live Covid.
AstraZeneca opted for a chimpanzee adenovirus, J&J for a human adenovirus.
Other Covid adenovirus vector vaccines include Russia's Sputnik V and China's CanSino.
Many European countries have continued to restrict the use of AstraZeneca, despite the EMA declaring it safe and saying blood clots are only a "very rare" side effect.
ETX Studio
Wed Apr 21 2021
Concerns over the vaccine by US pharmaceutical giant Johnson & Johnson and the jab by rival drugmaker AstraZeneca have dampened hopes that vaccines could offer a swift end to the pandemic. REUTERSpic
DSA : Simulator pesawat TUDM beri peluang pengunjung kendali pesawat pejuang
Simulator penerbangan FITs dibangunkan TUDM, memberi peluang kepada orang ramai merasai pengalaman mengendalikan pesawat pejuang.
Panggung Bangsawan Melaka platform perkasa seni, budaya tempatan - Ab Rauf
Panggung Bangsawan Melaka akan menjadi platform pemerkasaan industri seni dan budaya tempatan warisan kaum berbilang bangsa di negara ini.
Petani Kedah disaran tanam harumanis ekoran permintaan tinggi
Petani di Kedah disaran mengambil peluang mengusahakan tanaman mangga harumanis berikutan permintaan terhadap buah itu yang dinamakan sebagai Harumanis D'Aman sudah mula meraih perhatian.
Usaha gigih RIMAU untuk selamatkan harimau Malaya
Panthera Tigris Malayensis dilaporkan boleh ditemui di hutan Semenanjung Malaysia, terutamanya di Pahang, Perak, Terengganu dan Kelantan.
Polis geledah pejabat pemimpin Parlimen Eropah di Brussels
Pihak berkuasa Jerman melakukan penggeledahan di pejabat seorang ahli Parlimen Eropah di Brussels pada Selasa.
Kereta Safiq Rahim diserang dua lelaki bermotosikal
Selang dua hari selepas pemain Selangor FC Faisal Halim diserang, Safiq Rahim pula ditimpa malang apabila cermin keretanya dipecahkan menggunakan tukul besi.
Balu Navalny gesa rakyat Rusia tidak putus asa
Balu kepada pemimpin pembangkang Rusia Alexei Navalny, Yulia Navalnaya menggesa rakyat negara itu supaya tidak berputus asa memerangi rejim selepas pelantikan Vladimir Putin.
Perhimpunan Agung PBB mengundi Jumaat ini
Ia secara berkesan akan bertindak sebagai tinjauan global mengenai berapa banyak sokongan rakyat Palestin terhadap bidaan mereka, yang telah diveto dalam Majlis Keselamatan PBB bulan lalu oleh Amerika Syarikat.
Serangan di Rafah satu kesilapan, malapetaka kemanusiaan - PBB
Setiausaha Agung PBB Antonio Guterres pada Selasa memberi amaran kepada Israel bahawa serangan ke atas Rafah akan menjadi kesilapan strategik, bencana politik dan kemanusian.
Kehadiran Agong ke Parlimen kukuhkan lagi hubungan dua hala
Di bawah pemerintahan Yang Di-Pertuan Agong, Sultan Ibrahim selaku Sultan Negeri Johor, hubungan negeri itu dengan Singapura semakin kukuh.
Ia dapat dilihat dari segi ekonomi dan hubungan antara rakyat.
Ia dapat dilihat dari segi ekonomi dan hubungan antara rakyat.
Vaksin COVID-19: Malaysia lulus penggunaan kecemasan Sinopharm, Johnson & Johnson
Kelulusan pendaftaran bersyarat ini memerlukan maklumat kualiti, keselamatan dan keberkesanan produk vaksin tersebut dipantau dan dinilai.
COVID-19: Pakar optimis trend kematian di AS tidak seteruk tahun lalu
Profesor epidemiologi di Johns Hopkins University, Dr David Dowdy optimis kadar kematian tidak akan menyamai trend tahun lalu.
Vaksin COVID-19: Johnson & Johnson berkesan tangani varian Delta
Data menunjukkan ketahanan tindak balas imunisasi bagi penerima vaksinnya bertahan sekurang-kurangnya lapan bulan.
COVID-19: Suntikan ketiga vaksin AstraZeneca tingkatkan tindak balas imun
Suntikan ketiga vaksin AstraZeneca hasilkan tindak balas imun yang kuat
Penduduk Pulau Perhentian, Redang dijangka terima suntikan vaksin satu dos
Vaksin satu dos dilihat lebih bertepatan untuk disuntik kepada penduduk yang tinggal di kawasan tersebut.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
Mexico terima 1.35 juta dos vaksin Johnson & Johnson dari AS
Selepas selesai menerima suntikan vaksin, sekatan sempadan tidak akan diteruskan.
Sarawak sudah mohon peruntukan CanSino daripada Kerajaan Pusat
Sarawak telah menghantar permohonan kepada Kerajaan Pusat peruntukan menerima vaksin CanSino untuk kegunaan negeri itu.
Penggunaan CanSino dan Johnson & Johnson bantu percepatkan imuniti kelompok
Penggunaan dua jenis vaksin buatan CanSino dan Johnson & Johnson (J&J) dilihat mampu mempercepatkan sasaran pemberian vaksin terhadap seluruh masyarakat.
Vaksin CanSino, Johnson & Johnson diluluskan untuk pendaftaran bersyarat
Kedua-dua vaksin itu hanya memerlukan satu dos.